Furthermore, methylation of the CDKN2A promoter was associated with poor prognosis in PCa patients and was also closely related to the metabolism of copper ions in humans (Ameri et al., 2011; Silva et al., 2020). Here, CDKN2A is linked to posterior cortical atrophy.